Roles of volume-sensitive Cl- channel in cisplatin-induced apoptosis in human epidermoid cancer cells

T Ise1, T Shimizu, E L Lee

  • 1Department of Molecular Biology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu 807-8555, Japan.

Insights

Cisplatin-induced cancer cell death involves chloride channel activity. Blocking these channels with DIDS reduces cisplatin

Area of Science:

  • Cell Biology
  • Molecular Pharmacology
  • Cancer Research

Background:

  • Cisplatin is a chemotherapy drug that triggers apoptosis (programmed cell death) by damaging DNA.
  • Stilbene derivatives like SITS can confer cisplatin resistance, independent of intracellular pH or extracellular bicarbonate.
  • The role of chloride (Cl-) channels in cisplatin's mechanism of action and resistance is not fully understood.

Purpose of the Study:

  • To investigate the relationship between cisplatin-induced apoptosis and chloride channel activity in human adenocarcinoma KB cells.
  • To determine if DIDS, a stilbene derivative, affects cisplatin-induced cell death and resistance.
  • To characterize the chloride channels involved in KB cells and their response to cisplatin.

Main Methods:

  • Human adenocarcinoma KB cells were treated with cisplatin and/or DIDS.
  • Caspase-3 activation and cell death were measured over 18 hours.
  • Cell sensitivity to a 5-day cisplatin exposure was assessed.
  • Whole-cell patch-clamp recordings were used to analyze chloride channel activity.
  • KB cells were pretreated with cisplatin before patch-clamp analysis.

Main Results:

  • DIDS significantly reduced cisplatin-induced caspase-3 activation and cell death.
  • DIDS treatment decreased KB cell sensitivity to prolonged cisplatin exposure.
  • KB cells express functional volume-sensitive outwardly rectifying (VSOR) Cl- channels that are sensitive to DIDS.
  • Cisplatin pretreatment for 12 hours enhanced the activity of these VSOR Cl- channels.

Conclusions:

  • Cisplatin-induced cytotoxicity in KB cells is linked to increased activity of DIDS-sensitive VSOR Cl- channels.
  • Blockade of these VSOR Cl- channels by stilbene derivatives contributes to cisplatin resistance.
  • Targeting VSOR Cl- channels may offer a strategy to overcome cisplatin resistance in cancer therapy.